| 11/13/2026 5:03 PM | ADC Therapeutics (1771910) Subject Prosight Management, LP (1617201) Filed by | Form SCHEDULE 13G/A | |
| 11/09/2026 3:12 PM | ADC Therapeutics (1771910) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/09/2026 7:06 AM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/03/2026 4:02 PM | ADC Therapeutics (1771910) Filer | Form S-4 Registration statement under Securities Act of 1933 | |
| 10/29/2026 4:45 PM | ADC Therapeutics (1771910) Subject Bain Capital Life Sciences Opportunities IV, L.P. (2015553) Filed by | Form SCHEDULE 13G | |
| 10/13/2026 5:26 AM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2026 3:44 PM | ADC Therapeutics (1771910) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 07/02/2026 4:15 PM | ADC Therapeutics (1771910) Issuer MALLIK AMEET (1861441) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 4:16 PM | ADC Therapeutics (1771910) Issuer Carmona Jose (1693612) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 4:16 PM | ADC Therapeutics (1771910) Issuer GRAHAM PETER J (1235635) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 4:17 PM | ADC Therapeutics (1771910) Issuer Zaki Mohamed (2000697) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ADCT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ADC Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/24/2026 8:00 AM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/03/2026 4:02 PM | ADC Therapeutics (1771910) Issuer Coughlin Timothy (1376043) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 4:02 PM | ADC Therapeutics (1771910) Issuer BIZZARI JEAN-PIERRE (1630914) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 4:02 PM | ADC Therapeutics (1771910) Issuer Hug Peter (2000702) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 4:03 PM | ADC Therapeutics (1771910) Issuer Monges Viviane (1838204) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 4:03 PM | ADC Therapeutics (1771910) Issuer Sandor Victor (1620368) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 4:03 PM | ADC Therapeutics (1771910) Issuer Squarer Ron (1454001) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 4:03 PM | ADC Therapeutics (1771910) Issuer Azelby Robert (1656998) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 3:17 PM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 3:15 PM | ADC Therapeutics (1771910) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/04/2026 6:43 AM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/24/2026 8:31 PM | ADC Therapeutics (1771910) Subject Redmile Group, LLC (1425738) Filed by | Form SCHEDULE 13G/A | |
| 04/20/2026 8:01 AM | ADC Therapeutics (1771910) Filer | Form DEFA14A | |
| 04/20/2026 7:33 AM | ADC Therapeutics (1771910) Filer | Form DEF 14A | |
| 04/15/2026 3:20 PM | ADC Therapeutics (1771910) Filer | Form 424B3 | |
| 04/10/2026 3:15 PM | ADC Therapeutics (1771910) Filer | Form PRE 14A | |
| 04/06/2026 8:47 PM | ADC Therapeutics (1771910) Subject Redmile Group, LLC (1425738) Filed by | Form SCHEDULE 13G/A | |
| 04/02/2026 8:00 PM | ADC Therapeutics (1771910) Issuer Green Jeremy (1650527) Reporting RedCo II Master Fund, L.P. (1921783) Reporting Redmile Group, LLC (1425738) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/16/2026 11:15 PM | ADC Therapeutics (1771910) Filer | Form EFFECT | |
| 03/16/2026 4:02 PM | ADC Therapeutics (1771910) Filer | Form 424B3 | |
| 03/10/2026 3:44 PM | ADC Therapeutics (1771910) Filer | Form ARS | |
| 03/10/2026 6:58 AM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 6:15 AM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/18/2026 4:39 PM | ADC Therapeutics (1771910) Issuer MALLIK AMEET (1861441) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/18/2026 4:42 PM | ADC Therapeutics (1771910) Issuer Carmona Jose (1693612) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/18/2026 4:43 PM | ADC Therapeutics (1771910) Issuer GRAHAM PETER J (1235635) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/18/2026 4:43 PM | ADC Therapeutics (1771910) Issuer Zaki Mohamed (2000697) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/18/2026 4:44 PM | ADC Therapeutics (1771910) Issuer Kallebo Lisa Michelle (2000724) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 5:06 PM | ADC Therapeutics (1771910) Subject ORBIMED ADVISORS LLC (1055951) Filed by | Form SCHEDULE 13G/A | |
| 01/12/2026 7:37 AM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
The next convergence is here (Ad) In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months.
This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time.
Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it. See the three companies positioned for uranium's next supply shock |
| 01/08/2026 4:04 PM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/14/2025 11:15 PM | ADC Therapeutics (1771910) Filer | Form EFFECT | |
| 12/12/2025 3:33 PM | ADC Therapeutics (1771910) Filer | Form 424B3 | |
| 12/09/2025 4:09 PM | ADC Therapeutics (1771910) Issuer Carmona Jose (1693612) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 4:09 PM | ADC Therapeutics (1771910) Issuer GRAHAM PETER J (1235635) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 4:09 PM | ADC Therapeutics (1771910) Issuer Kallebo Lisa Michelle (2000724) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 4:09 PM | ADC Therapeutics (1771910) Issuer Zaki Mohamed (2000697) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 4:10 PM | ADC Therapeutics (1771910) Issuer MALLIK AMEET (1861441) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 3:32 PM | ADC Therapeutics (1771910) Filer | Form S-3/A | |
| 12/05/2025 4:00 PM | ADC Therapeutics (1771910) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |